These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 16061888)

  • 21. Anticoagulation quality and the risk of recurrence of venous thromboembolism.
    Poli D; Antonucci E; Ciuti G; Abbate R; Prisco D
    Thromb Haemost; 2007 Nov; 98(5):1148-50. PubMed ID: 18000626
    [No Abstract]   [Full Text] [Related]  

  • 22. Hemostatic management during oral surgery in patients with a left-ventricular assist system undergoing high-level anticoagulant therapy: efficacy of low molecular weight heparin.
    Morimoto Y; Niwa H; Hanatani A; Nakatani T
    J Oral Maxillofac Surg; 2008 Mar; 66(3):568-71. PubMed ID: 18280396
    [No Abstract]   [Full Text] [Related]  

  • 23. Low-molecular-weight heparin as bridging anticoagulation.
    van Dongen CJ; Vink R; Levi M
    Arch Intern Med; 2004 Dec 13-27; 164(22):2500. PubMed ID: 15596646
    [No Abstract]   [Full Text] [Related]  

  • 24. Guideline update. VTE disease: which agents, and when.
    Holten KB; Merok J
    J Fam Pract; 2009 Mar; 58(3):E1. PubMed ID: 19284934
    [No Abstract]   [Full Text] [Related]  

  • 25. [Use of low molecular weight heparin in women with recurrent pregnancy loss].
    Todorova K; Ivanov S
    Akush Ginekol (Sofiia); 2004; 43 Suppl 4():31-6. PubMed ID: 15673011
    [No Abstract]   [Full Text] [Related]  

  • 26. An evidence-based dentistry challenge: treating patients on warfarin (Coumadin).
    Goodchild JH; Donaldson M
    Dent Implantol Update; 2009 Jan; 20(1):1-8. PubMed ID: 19170364
    [No Abstract]   [Full Text] [Related]  

  • 27. Is laboratory monitoring of low-molecular-weight heparin therapy necessary? Yes.
    Harenberg J
    J Thromb Haemost; 2004 Apr; 2(4):547-50. PubMed ID: 15102006
    [No Abstract]   [Full Text] [Related]  

  • 28. Practical application of the 10-mg warfarin initiation nomogram.
    Wells PS; Le Gal G; Tierney S; Carrier M
    Blood Coagul Fibrinolysis; 2009 Sep; 20(6):403-8. PubMed ID: 19521238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Perioperative Bridging with Enoxaparin. Results of the Prospective BRAVE Registry with 779 Patients].
    Omran H; Hammerstingl C; Paar WD;
    Med Klin (Munich); 2007 Oct; 102(10):809-15. PubMed ID: 17928964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perioperative bridging therapy with unfractionated heparin or low-molecular-weight heparin in patients with mechanical prosthetic heart valves on long-term oral anticoagulants (from the REGIMEN Registry).
    Spyropoulos AC; Turpie AG; Dunn AS; Kaatz S; Douketis J; Jacobson A; Petersen H;
    Am J Cardiol; 2008 Oct; 102(7):883-9. PubMed ID: 18805116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Perioperative anticoagulant management.
    Grant PJ; Brotman DJ; Jaffer AK
    Med Clin North Am; 2009 Sep; 93(5):1105-21. PubMed ID: 19665623
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-molecular-weight heparin versus oral anticoagulant therapy for the long-term treatment of symptomatic venous thromboembolism: Is there any difference in cancer-related mortality?
    Ferretti G; Bria E; Giannarelli D; Carlini P; Felici A; Mandala M; Papaldo P; Nistico C; Fabi A; Cuppone F; Gelibter A; Terzoli E; Cognetti F
    J Clin Oncol; 2005 Oct; 23(28):7248-50; author reply 7250. PubMed ID: 16192623
    [No Abstract]   [Full Text] [Related]  

  • 33. Low-molecular-weight heparin as a bridging anticoagulant early after mechanical heart valve replacement.
    Meurin P; Tabet JY; Weber H; Renaud N; Ben Driss A
    Circulation; 2006 Jan; 113(4):564-9. PubMed ID: 16449734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Venous thromboembolism and cancer.
    Bergqvist D; Caprini JA; Dotsenko O; Kakkar AK; Mishra RG; Wakefield TW
    Curr Probl Surg; 2007 Mar; 44(3):157-216. PubMed ID: 17437761
    [No Abstract]   [Full Text] [Related]  

  • 35. Antithrombotic therapy in cancer.
    Lemoine NR
    J Clin Oncol; 2005 Apr; 23(10):2119-20. PubMed ID: 15699474
    [No Abstract]   [Full Text] [Related]  

  • 36. [Venous thromboprophylaxis postcaesarean: survey of practices in Lorraine].
    Vial F; Hein F; Boileau S; Vedel M; Bouaziz H
    Ann Fr Anesth Reanim; 2009 Apr; 28(4):395-6. PubMed ID: 19303734
    [No Abstract]   [Full Text] [Related]  

  • 37. Guidelines for antithrombotic therapy: periprocedural management of antithrombotic therapy and use of bridging anticoagulation.
    Spyropoulos AC; Douketis JD
    Int Angiol; 2008 Aug; 27(4):333-43. PubMed ID: 18677297
    [No Abstract]   [Full Text] [Related]  

  • 38. [Anticoagulants. Bridging anticoagulation with interventional techniques].
    Rüsing D
    Med Monatsschr Pharm; 2007 Nov; 30(11):426-7. PubMed ID: 18064750
    [No Abstract]   [Full Text] [Related]  

  • 39. [The prophylactic administration of low-molecular-weight heparin before surgery].
    Contreras Fernández R; Morillas Ramírez F; Ramírez Herrete M
    Rev Esp Cardiol; 2000 Feb; 53(2):301-2. PubMed ID: 10734765
    [No Abstract]   [Full Text] [Related]  

  • 40. The role of local low molecular weight heparin delivery in prevention of restenosis following coronary intervention.
    Deutsch E
    J Invasive Cardiol; 1999 Jun; 11 Suppl A():30A-32A. PubMed ID: 10745608
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.